One of my favorite things about working on the Health iPASS team is the opportunity to meet our community at trade shows and conferences so they can see with their own eyes the benefits of our solution. Myself and Health iPASS VP of Business Development Joel Rosenfield will be attending the 26th annual American Association of Dermatology Administrators (ADAM) meeting from February `12 - 14th at the Loews Coronado Bay Resort in San Diego, CA and would like to extend an invitation to schedule a demo and see firsthand the value of our our solution..
If you are attending the ADAM show next week, I encourage you to stop over to Table #14 so Joel and I can say hello and demonstrate how the Health iPASS solution helps Dermatology providers to promote price transparency, build patient trust, and increase operating income. We want to share case studies from other medical providers who are using the Health iPASS patient revenue cycle solution to streamline both time-of-service and residual patient payments through our intuitive and patient-friendly platform. We want you to know more about our partner providers who have enjoyed a 90 - 96% patient net collection rates, slashed denials by over 50% and have reduced the expense and time to collect from patients.
The continued surge of healthcare consumerism has prompted many medical providers to invest in patient revenue cycle solutions that essentially "pull back the curtain" on healthcare pricing and payment administration - traditionally a very complex and extremely confusing part of the industry. Times are changing though. Are you open and willing to be a part of the movement?
Extra incentive to visit Joel and I at Table #14 during the ADAM show: In case you missed the announcement, HealthiPASS launched a 2018 Social Responsinbility Initiative where we will donate $25 to The Greater Chicago Food Depository for each demo performed at our booths throughout the year.
Hope to see you at next week's ADAM Dermatology administrative conference! To schedule a demo - please click here,